Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cambrian Ventures LLP is a venture capital firm founded to accelerate healthcare innovation through investments in deep-tech ventures. Established in Singapore, the firm operates with a clear mission to address significant challenges in the healthcare sector by fostering partnerships and investing in transformative technologies. Cambrian Ventures is strategically positioned to enhance healthcare outcomes through its focus on innovative solutions.
Currently, Cambrian Ventures manages a diverse portfolio and operates across various investment stages, including seed, Series A, Series B, and growth equity. The firm emphasizes a global investment strategy, with a particular focus on Asia. Cambrian Ventures has established itself as a key player in the healthcare innovation space, leveraging its expertise to drive advancements in the industry.
Notable milestones include their commitment to addressing critical healthcare challenges through strategic partnerships and investments. The firm is headquartered at 1 Wallich Street, Guoco Tower, Singapore, and also maintains an office in London, UK. Cambrian Ventures is dedicated to improving healthcare outcomes and advancing the industry through its investments.
Cambrian Ventures invests in a variety of sectors within the healthcare industry, including longevity and cell and gene therapy, digital health and diagnostics, digital assets, and agri and food technologies. The firm emphasizes manufacturing value-chain aspects, particularly in scale-up and bioprocessing, which are crucial for the development of innovative healthcare solutions. Cambrian Ventures is particularly interested in wearables, early biomarker screening applications, and blockchain-enabled platforms that can enhance healthcare delivery.
In addition to these sectors, Cambrian Ventures targets cultured meat technologies and environmental impact mitigation within agri and food technologies. The firm seeks to invest in transformative technologies that address critical challenges in healthcare, focusing on deep-tech ventures that can significantly improve healthcare outcomes. Cambrian Ventures looks for founders who demonstrate a strong vision and capability to execute their ideas, particularly in the context of innovative healthcare solutions.
Cambrian Ventures has built a portfolio that includes several ventures aimed at enhancing healthcare outcomes through innovative technologies. Notable projects include:
These ventures reflect Cambrian Ventures' commitment to investing in technologies that can significantly impact healthcare delivery and patient outcomes. The firm actively seeks to support projects that align with its investment thesis of enhancing healthcare through deep-tech solutions.
Jin L. - Commercial Operation & Business Development. Jin has extensive experience in business development within the healthcare sector, focusing on operational strategies that drive growth.
Dr. O. - Biotech Strategy & Business Development. Dr. O. brings a wealth of knowledge in biotech, having led several successful projects in the field.
Dr. C. - Technology Strategy & Business Development. Dr. C. specializes in technology integration within healthcare, ensuring that Cambrian Ventures invests in cutting-edge solutions.
R. Tan - Digital Technology Lead. R. Tan focuses on digital health innovations, overseeing projects that leverage technology to improve healthcare delivery.
To pitch Cambrian Ventures, founders should send an email to ventures@cambrian-health.com. The pitch deck should include a clear overview of the business model, market analysis, and technology details. Cambrian Ventures appreciates concise and well-structured presentations that highlight the unique value proposition of the startup.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, Cambrian Ventures has been actively engaged in the healthcare sector, emphasizing partnerships and investments in innovative technologies. Notable updates include their focus on AI-driven solutions for heart failure patient triage and the development of a patented oral health device.
The firm continues to explore opportunities in the agri-tech space, particularly in cultured meat technologies, reflecting their commitment to addressing environmental impacts through innovative solutions.
What are Cambrian Ventures' investment criteria?
Cambrian Ventures focuses on deep-tech ventures within the healthcare sector, particularly those addressing critical challenges. They invest in various stages, including seed, Series A, Series B, and growth equity, with a strong emphasis on transformative technologies.
How can I apply or pitch to Cambrian Ventures?
Founders can pitch their ideas by emailing ventures@cambrian-health.com. It is advisable to include a detailed deck outlining the business model, market opportunity, and technology involved.
What makes Cambrian Ventures different from other investors?
Cambrian Ventures distinguishes itself through its focus on deep-tech healthcare innovations and its commitment to partnerships that enhance healthcare outcomes. Their expertise in manufacturing value-chain aspects and blockchain technologies sets them apart.
What is Cambrian Ventures' geographic scope?
The firm operates globally, with a particular focus on Asia. Cambrian Ventures seeks to invest in healthcare innovations that can have a significant impact in these regions.
What is Cambrian Ventures' post-investment involvement like?
Cambrian Ventures actively engages with its portfolio companies, providing operational support and strategic guidance to help them scale and succeed in the healthcare market.
What is the typical check size Cambrian Ventures invests?
The firm invests across various stages, and while specific check sizes are not disclosed, they typically align with the funding needs of seed to growth equity rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.